Exam Preview for 40854: Ménière’s Disease

Ménière’s Disease - How I See It and Do It!

Please note: exam questions are subject to change.

1. Which of the following is NOT a criterion for definite Ménière’s disease according to the 2015 ICVD guidelines? At least two spontaneous vertigo episodes lasting 20 minutes to 12 hours Persistent symptoms of dizziness lasting over 24 hours Documented low- to mid-frequency sensorineural hearing loss Fluctuating aural symptoms such as tinnitus or ear fullness
2. What is a key difference between probable and definite Ménière’s disease in the 2015 ICVD classification? At least two spontaneous vertigo episodes lasting 20 minutes to 12 hours Persistent symptoms of dizziness lasting over 24 hours Documented low- to mid-frequency sensorineural hearing loss Fluctuating aural symptoms such as tinnitus or ear fullness
3. Which test combination best helps differentiate Ménière’s disease from vestibular migraine? MRI with contrast and tympanometry ABR and speech audiometry vHIT and caloric testing OAE and posturography
4. According to Dr. Karlberg, which treatment for Ménière’s disease has demonstrated the highest rate of vertigo control? Intratympanic latanoprost Spironolactone Intratympanic gentamicin Antivertigo medication only
5. Which of the following treatment approaches is considered minimally invasive and reversible, and has shown positive results for vertigo control in Ménière’s disease? Labyrinthectomy Grommet insertion Vestibular nerve section Cortical implantation